Senior Director, Pipeline Market Access Strategy - Specialty, Obesity & Eye Care

AbbVie•Florham Park, NJ

8h•$206,500 - $393,000

About The Position

The Senior Director, Pipeline Market Access Strategy is a newly created role responsible for leading the end-to-end global market access strategy for pipeline assets within an assigned Business Unit. The position guides the organization through external pressures on pharmaceutical pricing and reimbursement and embeds access considerations into drug development from early stages through Phase 3 design and evidence planning. It defines distinct US and international strategies to support global launch success. The Senior Director leads experts in US and International Pipeline Strategy and sets the team's objectives and vision. The role partners with inline access teams and with R&D, Regulatory, HEOR, Global Commercial Development, Business Development, Government Affairs, and other functions to develop integrated strategies that support long-term commercial performance and patient access. The role owns pipeline integrated access strategies for pre-launch and development-stage assets, represents access priorities in governance and portfolio decisions, and oversees access roadmaps, evidence planning, and launch readiness. It also contributes market access expertise to business development evaluations and due diligence, while building and developing a high-performing team across US and international functions. Travel is required 25% of the time.

Requirements

Advanced degree (MBA, MPH, PhD, PharmD, or equivalent) in business, health economics, public policy, life sciences, or a related field.
Bachelor's degree in a scientific, business, or public health discipline as a minimum baseline.
12–15 years of progressive senior-level experience in market access, pricing, reimbursement, HEOR, or a closely related pharmaceutical or biopharmaceutical function, with substantial experience in pipeline and pre-launch strategy.
Global market access expertise, including working knowledge of HTA processes, payer evidence requirements, pricing and reimbursement frameworks, and access decision-making across the US, EU5, Japan, and other key markets.
Experience shaping clinical development strategy from a market access and outcomes evidence perspective, including contributing to clinical trial design, endpoint selection, and Integrated Evidence Plan development with R&D.
Track record leading and developing high-performing teams in a matrixed, multinational environment, managing direct reports and influencing cross-functional partners without direct authority.
Ability to communicate complex access strategy to executive audiences and influence enterprise-level pipeline investment decisions.
Deep expertise in at least one therapeutic area.

Nice To Haves

Formal training or demonstrated expertise in health technology assessment, health economics, outcomes research, or pharmaceutical development.
Experience supporting Business Development activities, including asset due diligence, licensing evaluations, and access-based valuation assessments.
Experience across multiple therapeutic areas, such as Oncology, Immunology, or Neuroscience.

Responsibilities

Own end-to-end integrated market access strategies for pre-launch and development-stage assets within the assigned Business Unit, incorporating evidence needs, policy considerations, pricing potential, and commercial considerations through regulatory submission.
Represent pipeline market access strategy at Business Unit governance forums and senior leadership reviews, clearly communicating access risks, opportunities, and strategic direction.
Provide market access input to pipeline Business Development opportunities and due diligence.
Prioritize pipeline assets and allocate resources based on access complexity and business impact.
Develop launch strategies that address IRA, MFN, US channel dynamics, indication and geographic sequencing, and other market forces.
Define and deliver cross-functional Access Roadmaps for pipeline assets, including development-phase approaches, anticipated launch timing, and global evidence deliverables.
Partner with R&D and Regulatory to incorporate access-relevant endpoints, comparators, and trial design elements into clinical programs from Phase I/II onward.
Define and champion market-access-informed Target Product Profiles and translate payer value requirements into clinical and evidence-generation guidance.
Generate and maintain global payer and HTA evidence requirements across the US, EU5, Japan, and emerging markets.
Direct the US Pipeline Strategy Lead and International Pipeline Strategy Lead and integrate domestic and global perspectives into a cohesive Business Unit strategy.
Align US payer, formulary, and value communication strategies with international HTA, pricing, and reimbursement approaches, adapting to local requirements.
Anticipate cross-market reference pricing dynamics, parallel trade risks, and HTA precedent effects in pipeline strategies.
Develop and execute a pipeline-to-launch transition framework, ensuring strategies, payer evidence packages, and reimbursement submissions are prepared before regulatory approval.
Coordinate knowledge transfer and strategic handoff with US and international commercial, medical, and market access teams at regulatory approval.
Lead cross-functional launch-readiness reviews and resolve evidence, pricing approval, and formulary positioning gaps before approval.
Equip affiliate and in-country market access teams with aligned value messages, health economic tools, and reimbursement dossiers ahead of launch.
Provide strategic direction to HEOR, R&D, Regulatory, Global Commercial Development, Global Marketing, Government Affairs, and Business Development.
Lead development of Integrated Evidence Plans with HEOR, aligning real-world evidence, health economic modeling, and outcomes research with payer and HTA requirements.
Partner with Government Affairs to anticipate policy and reimbursement changes and incorporate policy risks and opportunities into strategies.
Align pipeline access strategies with brand positioning, indication sequencing, and long-range commercial forecasts.
Inform in-licensing, partnership, and acquisition decisions through payer landscape assessments, reimbursement probability analyses, and access risk evaluations.
Establish and communicate access-based licensing priorities that account for evidence requirements, competitive access dynamics, and global pricing sustainability.
Assess payer readiness and evidence maturity of external pipeline assets during due diligence.
Represent pipeline access priorities in senior leadership forums, portfolio review committees, and cross-Business Unit strategy sessions.
Build, develop, and retain a high-performing pipeline access team, including mentorship, career development, and performance management for direct and indirect reports.
Foster innovation, rigor, and affiliate-centricity, incorporating affiliate launch needs, in-country market dynamics, and local payer requirements into global strategy.